about
Use of procalcitonin and C-reactive protein to evaluate vaccine efficacy against pneumoniaClinical and Microbiological Features of Salmonella Meningitis in a South African Population, 2003-2013Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trialSurveillance for antimicrobial drug resistance in under-resourced countriesThe anticipated severity of a "1918-like" influenza pandemic in contemporary populations: the contribution of antibacterial interventionsPersistent high burden of invasive pneumococcal disease in South African HIV-infected adults in the era of an antiretroviral treatment programPneumococcal pneumonia and influenza: a deadly combination.Interaction between influenza virus and Streptococcus pneumoniae in severe pneumonia.Fluoroquinolone resistance among clinical isolates of Streptococcus pneumoniae belonging to international multiresistant clones.Assessing the Evidence for Maternal Pertussis Immunization: A Report From the Bill & Melinda Gates Foundation Symposium on Pertussis Infant Disease Burden in Low- and Lower-Middle-Income Countries.Public health and economic impact of vaccination with 7-valent pneumococcal vaccine (PCV7) in the context of the annual influenza epidemic and a severe influenza pandemic.Efficacy of whole-cell killed bacterial vaccines in preventing pneumonia and death during the 1918 influenza pandemic.Contribution of vaccines to our understanding of pneumococcal disease.Impact of 13-valent pneumococcal conjugate vaccine (PCV13) in a pandemic similar to the 2009 H1N1 in the United StatesUse of near-real-time medical claims data to generate timely vaccine coverage estimates in the US: the dynamics of PCV13 vaccine uptake.Association between respiratory syncytial virus activity and pneumococcal disease in infants: a time series analysis of US hospitalization data.Streptococcus pneumoniae Serotypes and Mortality in Adults and Adolescents in South Africa: Analysis of National Surveillance Data, 2003 - 2008.220D-F2 from Rubus ulmifolius kills Streptococcus pneumoniae planktonic cells and pneumococcal biofilms.Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae.Interrelationship of Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus colonization within and between pneumococcal-vaccine naïve mother-child dyads.Nasopharyngeal Pneumococcal Serotypes Before and After Mass Azithromycin Distributions for Trachoma.An unusual pneumococcal sequence type is the predominant cause of serotype 3 invasive disease in South AfricaReply to "no clinical association of live attenuated influenza vaccine with nasal carriage of bacteria or acute otitis media": specific recommendations for future studiesImpact of experimental human pneumococcal carriage on nasopharyngeal bacterial densities in healthy adults.PERCH in Perspective: What Can It Teach Us About Pneumonia Etiology in Children?Contribution of Serologic Assays in the Evaluation of Influenza Virus Infection Rates and Vaccine Efficacy in Pregnant Women: Report From Randomized Controlled Trials.Re-examination of immune response and estimation of anti-Vi IgG protective threshold against typhoid fever-based on the efficacy trial of Vi conjugate in young childrenFactors associated with ceftriaxone nonsusceptibility of Streptococcus pneumoniae: analysis of South African national surveillance data, 2003 to 2010.Interspecies recombination in type II topoisomerase genes is not a major cause of fluoroquinolone resistance in invasive Streptococcus pneumoniae isolates in the United States.Global practices of meningococcal vaccine use and impact on invasive disease.Estimated severe pneumococcal disease cases and deaths before and after pneumococcal conjugate vaccine introduction in children younger than 5 years of age in South AfricaVirulence characteristics of Klebsiella and clinical manifestations of K. pneumoniae bloodstream infections.Variable recombination dynamics during the emergence, transmission and 'disarming' of a multidrug-resistant pneumococcal cloneMaternal influenza immunization and reduced likelihood of prematurity and small for gestational age births: a retrospective cohort study.Novel mechanism of resistance to oxazolidinones, macrolides, and chloramphenicol in ribosomal protein L4 of the pneumococcusEffect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infantsCohort profile: The study of respiratory pathogens in Andean childrenEvidence for soft selective sweeps in the evolution of pneumococcal multidrug resistance and vaccine escape.Pneumococcal colonisation density: a new marker for disease severity in HIV-infected adults with pneumonia.Defining the estimated core genome of bacterial populations using a Bayesian decision model.
P50
Q24794396-FDAFDF58-8F78-4835-9823-C96C0B3EF31EQ27002573-E6021CF4-2CAC-472C-9B3B-5D7AAF4C6F5DQ28262067-B6A1E27F-4B03-4582-94EB-F403B4AF716CQ28658135-3C8E8CCF-DEDC-40FE-B063-49C87C242669Q28732491-49477A07-AF35-4D65-84C8-26E985ABDD8DQ28742203-C8D13820-47DC-45C6-89C2-49DAF7FE1309Q30227641-7B0F9950-E627-435B-A3D7-C045A991F4A9Q30228581-A364149C-820E-4B40-BB0F-F5C3436D0CF8Q30329277-F577A9DA-DA99-4A18-8736-A325AD5B8AA9Q30380537-BE0DE8CD-1697-43AC-8E80-118693CF3117Q30384713-21C3F839-4A68-424A-8C62-14843ECD5E49Q30395482-7A15E41C-51CE-4828-B015-E50CF0C329DEQ30406750-7FDF55BC-3FAC-4C4F-A581-99BBFF2671A3Q30430741-57E32F3C-3F1A-4233-8F17-A850BE6A210FQ30681367-BB5681E4-4518-4882-B460-EB3270520629Q30882879-4FD20D22-CAF2-4C54-BF51-5093615CB529Q31004642-82CA482A-04D9-4F51-B51A-4C8E2730A36BQ31161118-EBD7583E-1357-4CAE-B8CE-B8A7A250C7F6Q33264145-35B37E0E-8AB0-419A-AAB3-489AF8DF1411Q33589966-33567781-5A22-40D7-99A7-FBF1256F3EBAQ33609239-407DE932-5F3D-4D4B-8B8A-62F2A20CC6D6Q33614192-75DB9510-771A-4FBA-9E51-C82EF2A322F9Q33648078-35B158DE-9861-4A95-8054-0EC8F3CB018DQ33734282-62BCD6A9-8C7C-4765-B0CF-7262439EC271Q33736967-068AC1E8-93A6-47E3-A984-95C5E8F31ED5Q33737096-C0A4FEE0-506A-421E-9B48-8F21E915E30EQ33797264-64A287A5-D8C5-4711-84C6-3E582ACE7A00Q33798133-8A9B55E6-C1C0-4D9A-BD4D-13C819633B8CQ33806725-85BE0DC3-6D79-4264-BB08-4D9628226E74Q33850840-61A5606E-C279-4575-82C0-72293B0CDEB8Q33865533-DD25F246-2EE5-465E-9C7F-0F1D2DF89F85Q33884115-9FDE228D-D24A-4BCD-8DB8-0EB89CC910DCQ33891667-42187F85-560B-409A-9251-1A3D82911B0CQ33927386-85A3AB23-16DD-442F-9C0F-BDDBC4BF3476Q33938088-C2A8FF54-4EDF-43C8-8726-EE7C986971B6Q33988269-ADDC05E7-53CC-4768-BEEC-7704916F2DE9Q34001180-5120D89C-FDCF-488B-BB0D-7ACBDE5FE28DQ34007220-A75DB630-896B-4A7C-A1EE-1044A4B7577FQ34024693-DB270508-2099-4EF9-AE12-5DD01D6DF672Q34075033-5C11750F-B0AA-4901-94D3-D586BEB5AB60
P50
name
Keith P. Klugman
@en
Keith P. Klugman
@nl
type
label
Keith P. Klugman
@en
Keith P. Klugman
@nl
altLabel
K P Klugman
@en
K. Klugman
@en
K. P. Klugman
@en
Keith Klugman
@en
Keith P Klugman
@en
Klugman K
@en
Klugman K. P.
@en
Klugman K.
@en
Klugman KP
@en
Klugman
@en
prefLabel
Keith P. Klugman
@en
Keith P. Klugman
@nl
P1960
T-mgWmkAAAAJ